Anatase and rutile titanium oxide nanoparticles induce acute kidney injury by coadministration with paraquat, cisplatin or 5-aminosalicylic acid
Nanoparticles are used in a variety of fields; for example, titanium oxide nanoparticles are used in paints, food additives, cosmetics, and sunscreen materials. Although the use of titanium oxide nanoparticles is regulated, their safety has not been established. Furthermore, the interaction between titanium oxide nanoparticles and various chemical substances and pharmaceuticals is unknown. We co-administered rutile-type titanium oxide nanoparticles (nTR) or anatase-type titanium oxide nanoparticles (nTA) to mice together with paraquat (PQ), cisplatin (CDDP), or anti-5-aminosalicylic acid (5-ASA), and investigated the extent, if any, of liver and kidney injury. As a result, when nTA and nTR were administered alone, no increases were observed in aspartate aminotransferase (AST) and alanine aminotransferase (ALT), which are indicators of liver damage, or urea nitrogen (BUN), which is an indicator of kidney damage. Next, nTA and nTR were co-administered with PQ, CDDP or 5-ASA. Although no increase in ALT or AST was observed, BUN levels increased significantly and acute kidney injury was induced. The findings suggested that titanium oxide nanoparticles induce acute kidney injury through their interaction with chemicals and drugs.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:79 |
---|---|
Enthalten in: |
Die Pharmazie - 79(2024), 1 vom: 29. Feb., Seite 2-5 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Kamiyama, H [VerfasserIn] |
---|
Links: |
---|
Themen: |
15FIX9V2JP |
---|
Anmerkungen: |
Date Completed 22.03.2024 Date Revised 05.04.2024 published: Print Citation Status MEDLINE |
---|
doi: |
10.1691/ph.2024.3655 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM369992105 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM369992105 | ||
003 | DE-627 | ||
005 | 20240405233917.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240322s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1691/ph.2024.3655 |2 doi | |
028 | 5 | 2 | |a pubmed24n1366.xml |
035 | |a (DE-627)NLM369992105 | ||
035 | |a (NLM)38509631 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Kamiyama, H |e verfasserin |4 aut | |
245 | 1 | 0 | |a Anatase and rutile titanium oxide nanoparticles induce acute kidney injury by coadministration with paraquat, cisplatin or 5-aminosalicylic acid |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 22.03.2024 | ||
500 | |a Date Revised 05.04.2024 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Nanoparticles are used in a variety of fields; for example, titanium oxide nanoparticles are used in paints, food additives, cosmetics, and sunscreen materials. Although the use of titanium oxide nanoparticles is regulated, their safety has not been established. Furthermore, the interaction between titanium oxide nanoparticles and various chemical substances and pharmaceuticals is unknown. We co-administered rutile-type titanium oxide nanoparticles (nTR) or anatase-type titanium oxide nanoparticles (nTA) to mice together with paraquat (PQ), cisplatin (CDDP), or anti-5-aminosalicylic acid (5-ASA), and investigated the extent, if any, of liver and kidney injury. As a result, when nTA and nTR were administered alone, no increases were observed in aspartate aminotransferase (AST) and alanine aminotransferase (ALT), which are indicators of liver damage, or urea nitrogen (BUN), which is an indicator of kidney damage. Next, nTA and nTR were co-administered with PQ, CDDP or 5-ASA. Although no increase in ALT or AST was observed, BUN levels increased significantly and acute kidney injury was induced. The findings suggested that titanium oxide nanoparticles induce acute kidney injury through their interaction with chemicals and drugs | ||
650 | 4 | |a Journal Article | |
650 | 7 | |a Cisplatin |2 NLM | |
650 | 7 | |a Q20Q21Q62J |2 NLM | |
650 | 7 | |a Paraquat |2 NLM | |
650 | 7 | |a PLG39H7695 |2 NLM | |
650 | 7 | |a titanium dioxide |2 NLM | |
650 | 7 | |a 15FIX9V2JP |2 NLM | |
650 | 7 | |a Mesalamine |2 NLM | |
650 | 7 | |a 4Q81I59GXC |2 NLM | |
650 | 7 | |a Titanium |2 NLM | |
650 | 7 | |a D1JT611TNE |2 NLM | |
700 | 1 | |a Nonaka, C |e verfasserin |4 aut | |
700 | 1 | |a Saitoh, H |e verfasserin |4 aut | |
700 | 1 | |a Ohno, M |e verfasserin |4 aut | |
700 | 1 | |a Shimizu, Y |e verfasserin |4 aut | |
700 | 1 | |a Isoda, K |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Die Pharmazie |d 1947 |g 79(2024), 1 vom: 29. Feb., Seite 2-5 |w (DE-627)NLM000009180 |x 0031-7144 |7 nnns |
773 | 1 | 8 | |g volume:79 |g year:2024 |g number:1 |g day:29 |g month:02 |g pages:2-5 |
856 | 4 | 0 | |u http://dx.doi.org/10.1691/ph.2024.3655 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 79 |j 2024 |e 1 |b 29 |c 02 |h 2-5 |